Unusually Long Survival from Diagnosis (More Than Three Years to More Than 29 Years) in 27 Glioblastoma Patients Treated with Antineoplastons in Phase II Studies
Stanislaw R Burzynski,
Gregory S Burzynski,
Tomasz J Janicki,
Radoslaw J Siwiec,
Samuel W Beenken
